Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous ...

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce ...
Bored Panda on MSN

51 times people delivered karma to bosses who 100% deserved it

When you hate your boss, the grass is no longer green, the birds stop chirping, and the world seems bleak. A bad workplace ...
PrintWeek India

WhatPackaging? Team

The WhatPackaging? team visited the stall and spoke to the Pune-based manufacturer about the coating. Over a decade, the IndiaCorr Expo and India Folding Carton has proved to be a solid platform for ...